Sign Up to like & get
recommendations!
0
Published in 2019 at "Experimental cell research"
DOI: 10.1016/j.yexcr.2019.05.021
Abstract: Acute myelogenous leukemia (AML) is a hematological malignancy marked by the accumulation of large numbers of immature myeloblasts in bone marrow. The overall prognosis in AML is poor; hence, there is a pressing need to…
read more here.
Keywords:
drug regimen;
myelogenous leukemia;
pivotal role;
ceramide tamoxifen ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nb2021-0380
Abstract: A three-drug regimen containing the CTLA4 inhibitor tremelimumab plus the PD-L1 inhibitor durvalumab and chemotherapy may be an effective first-line treatment strategy for patients with metastatic non-small cell lung cancer. In the phase III POSEIDON…
read more here.
Keywords:
three drug;
drug regimen;
chemo nsclc;
bests chemo ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e17073
Abstract: e17073Background: Despite initial response rates to standard platinum-based chemotherapy for EOC/FT/PP, the majority of patients relapse. The purpose of this study was to describe response and tole...
read more here.
Keywords:
regimen gemcitabine;
fluorouracil irinotecan;
use multi;
drug regimen ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Gastroenterology and Hepatology From Bed to Bench"
DOI: 10.22037/ghfbb.v12i3.1500
Abstract: Aim: This study compares the effects of two drug regimens for Helicobacter pylori (H. pylori) infection resistant to the first line drug regimen among patients referred to Ilam clinics, Iran. Background: Single drug regimen is…
read more here.
Keywords:
drug regimen;
drug;
treatment;
ppi amoxicillin ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.1015510
Abstract: There are many treatments for metastatic colorectal cancer (mCRC). Among them, uncertainty remains especially concerning the clinical benefit of different regimens for left-sided RAS wild-type (WT) mCRC in the triple-drug therapy era. No studies have…
read more here.
Keywords:
left sided;
double drug;
triple drug;
sided ras ... See more keywords